ADAR and cancer: In addition, siADAR1 can be effectively delivered to cancer cells through nanoparticles designed to silence ADAR1 expression, leading to increased production of type I interferon, making cancer cells more sensitive to secreted effector cytokines and significantly halting cell growth [113].